Literature DB >> 6234255

Cyclosporine-induced alterations of humoral response in experimental autoimmune uveitis.

C C Chan, A G Palestine, R B Nussenblatt.   

Abstract

Cyclosporine (CsA) has been shown to be effective in preventing S-antigen (S-Ag) induced experimental autoimmune uveitis (EAU) in Lewis rats. Alterations in the humoral immune responses associated with CsA therapy are illustrated by lower peak and delayed production of circulating anti-S-Ag antibodies in a proportional relationship to the dose of CsA in EAU. Circulating immune complexes were not detected in rats with EAU or in rats treated with CsA and without disease. These findings further support the important role of T-cells in EAU and further demonstrate the effect of CsA on helper T-cells. The kinetics of antibody production by S-Ag-immunized rats appears altered by CsA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234255

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Circulating immune complexes may play a regulatory and pathogenic role in experimental autoimmune uveoretinitis.

Authors:  E Kasp; M R Stanford; E Brown; A G Coombes; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Precipitation of experimental autoallergic uveoretinitis by cyclosporin A withdrawal: an experimental model of uveitis relapse.

Authors:  E G Atkinson; W J Dinning; E Kasp; E M Graham; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans.

Authors:  A G Palestine; F Roberge; B L Charous; H C Lane; A S Fauci; R B Nussenblatt
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.